US Stock MarketDetailed Quotes
RGC Regencell Bioscience
- 5.330
- -1.160-17.87%
Close May 3 16:00 ET
69.36MMarket Cap-11844P/E (TTM)
6.310High4.850Low5.28KVolume6.210Open6.490Pre Close30.08KTurnover0.36%Turnover RatioLossP/E (Static)13.01MShares30.49052wk High5.77P/B7.79MFloat Cap3.16052wk Low--Dividend TTM1.46MShs Float59.000Historical High--Div YieldTTM22.50%Amplitude3.160Historical Low5.694Avg Price1Lot Size
About Regencell Bioscience Company
Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.
Company Profile
SymbolRGC
Company NameRegencell Bioscience
Listing DateJul 16, 2021
Issue Price9.50
Founded2014
CEOMr. Yat-Gai Au
MarketNASDAQ
Employees12
Securities TypeOrdinary Shares
Fiscal Year Ends06-30
AddressChinachem Leighton Plaza,29 Leighton Road,9th Floor, Causeway Bay
CityHong Kong，China
ProvinceHK
CountryChina
Phone852-2155-0823
Company Executives
- Name
- Position
- Salary
- Yat-Gai Au
- Chief Executive Officer and Chairman of the Board
- --
- James Wai Hong Chung
- Chief Operation Officer and Chief Strategy Officer; Senior Vice President, Regencell Bioscience Limited
- 245.64K
- Yat-Pui Au
- Chief Business Officer; Senior Vice President, Regencell Bioscience Limited
- --
- Dr. Yi-Chung Chao, PhD
- Director
- 249.74K
- Paul J. Niewiadoi
- Independent Director
- --
- Dr. Wing Yan William Lo
- Independent Director
- --
- Evana Yee Wah Hui
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg